Pence charged with fronting coronavirus risk, Azar says he’s still in charge of taskforce

President Trump put Vice President Mike Pence in charge of the coronavirus epidemic during a press briefing Feb. 26, but HHS Secretary Alex Azar said he is still chairman of the press conference.

The administration recently asked for $2.5 billion in additional funding to mitigate the coronavirus, which has been called COVID-19 and has sickened thousands worldwide. The vast majority of the cases are confined to China, where the novel coronavirus originated, but cases have also spread to the U.S. Officials also believe a wider spread in the U.S. is “inevitable,” former director of the CDC Tom Friedman wrote in an editorial for CNN.

Trump noted that Pence would lead the response from the U.S. government to fight the coronavirus.

“I'm going to be putting our Vice President Mike Pence in charge, and Mike will be working with the professionals, doctors and everybody else that's working,” he said during the televised briefing.

Azar noted he did not feel replaced by Pence when asked by reporters.

The impact on financial markets due to fears and risks of the virus have been severe, with stocks plunging worldwide. Healthcare stocks in particular have been hard hit.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”